<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Ribavirin</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Ribavirin">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Ribavirin</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Ribavirin</b>, also known as <b>tribavirin</b>, is an antiviral medication used to treat RSV infection, hepatitis C and some viral hemorrhagic fevers.<span class="mw-ref" id="cite_ref-AHFS2016_1-2"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> For hepatitis C, it is used in combination with other medications such as simeprevir, sofosbuvir, peginterferon alfa-2b or peginterferon alfa-2a.<span class="mw-ref" id="cite_ref-AHFS2016_1-3"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Among the viral hemorrhagic fevers it is used for Lassa fever, Crimean–Congo hemorrhagic fever, and Hantavirus infection but should not be used for Ebola or Marburg infections.<span class="mw-ref" id="cite_ref-AHFS2016_1-4"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Ribavirin is taken by mouth or inhaled.<span class="mw-ref" id="cite_ref-AHFS2016_1-5"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>




<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Ribavirin</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Ribavirin.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Ribavirin.svg.png" data-file-width="512" data-file-height="493" data-file-type="drawing" height="169" width="175"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Ribavirin-from-xtal-Mercury-3D-bs.png" tppabs="https://ptable.com/wiki/compounds/I/m/Ribavirin-from-xtal-Mercury-3D-bs.png" data-file-width="2000" data-file-height="1358" data-file-type="bitmap" height="136" width="200"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pronunciation</th><td><span class="rt-commentedText nowrap"><span class="IPA nopopups noexcerpt">/<span style="border-bottom:1px dotted"><span>ˌ</span><span>r</span><span>aɪ</span><span>b</span><span>ə</span><span>ˈ</span><span>v</span><span>aɪ</span><span>r</span><span>ɪ</span><span>n</span></span>/</span></span>  <i title="English pronunciation respelling"><span style="font-size:90%">RY</span>-bə-<span style="font-size:90%">VY</span>-rin</i><span> </span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Copegus, Rebetol, Virazole, other<span class="mw-ref" id="cite_ref-AHFS2016_1-0"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Other names</th><td>1-(β-<small>D</small>-Ribofuranosyl)-1<i>H</i>-1,2,4-triazole-3-carboxamide, tribavirin (BAN <small><abbr>UK</abbr></small>)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/ribavirin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/ribavirin.html'" tppabs="https://www.drugs.com/monograph/ribavirin.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a605018.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a605018.html'" tppabs="https://medlineplus.gov/druginfo/meds/a605018.html" class="external text external">a605018</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Ribavirin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Ribavirin'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Ribavirin" class="external text external">by INN</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>X (High risk)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>X (Contraindicated)<span> </span><span class="mw-ref" id="cite_ref-AHFS2016_1-1"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth, solution for inhalation</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>J05AP01<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=J05AP01  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=J05AP01'" tppabs="https://www.whocc.no/atc_ddd_index/?code=J05AP01" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>S4 (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">CA</abbr></small>:<span> </span> ℞-only<span> </span></li>
<li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>64%<span class="mw-ref" id="cite_ref-TGA_2-0"><a href="#cite_note-TGA-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>0%<span class="mw-ref" id="cite_ref-TGA_2-1"><a href="#cite_note-TGA-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>liver and intracellularly<span class="mw-ref" id="cite_ref-TGA_2-2"><a href="#cite_note-TGA-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>298 hours (multiple dose); 43.6 hours (single dose)<span class="mw-ref" id="cite_ref-TGA_2-3"><a href="#cite_note-TGA-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>Urine (61%), faeces (12%)<span class="mw-ref" id="cite_ref-TGA_2-4"><a href="#cite_note-TGA-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">1-[(2<i>R</i>,3<i>R</i>,4<i>S</i>,5<i>R</i>)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1<i>H</i>-1,2,4-triazole-3-carboxamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=36791-04-5  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=36791-04-5'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=36791-04-5" class="external text external">36791-04-5</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/37542  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/37542'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/37542" class="external text external">37542</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6842  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6842'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6842" class="external text external">6842</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00811  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00811'" tppabs="https://www.drugbank.ca/drugs/DB00811" class="external text external">DB00811</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.34439.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.34439.html'" tppabs="http://www.chemspider.com/Chemical-Structure.34439.html" class="external text external">34439</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=49717AWG6K  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=49717AWG6K'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=49717AWG6K" class="external text external">49717AWG6K</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D00423  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D00423'" tppabs="https://www.kegg.jp/entry/D00423" class="external text external">D00423</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1643  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1643'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL1643" class="external text external">ChEMBL1643</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">NIAID ChemDB</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=000053  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=000053'" tppabs="https://chemdb.niaid.nih.gov/CompoundDetails.aspx?AIDSNO=000053" class="external text external">000053</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PDB ligand</th><td><div class="plainlist"><ul><li>RBV (<span><a href="javascript:if(confirm('https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=RBV  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=RBV'" tppabs="https://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=RBV" class="external text external">PDBe</a></span>, <span><a href="javascript:if(confirm('http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=RBV&polymericType=Any  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=RBV&polymericType=Any'" tppabs="http://www.rcsb.org/pdb/search/smartSubquery.do?smartSearchSubtype=ChemCompIdQuery&chemCompId=RBV&polymericType=Any" class="external text external">RCSB<span>&nbsp;</span>PDB</a></span>)</li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID8023557  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID8023557'" tppabs="https://comptox.epa.gov/dashboard/DTXSID8023557" class="external text external">DTXSID8023557</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.164.587  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.164.587'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.164.587" class="external text external">100.164.587</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>8</sub><span>H</span><sub>12</sub><span>N</span><sub>4</sub><span>O</span><sub>5</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">244.207</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=OC%5BC%40%40H%5D%28O1%29%5BC%40%40H%5D%28O%29%5BC%40%40H%5D%28O%29%5BC%40%40H%5D1N2N%3DC%28C%28N%29%3DO%29N%3DC2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=OC%5BC%40%40H%5D%28O1%29%5BC%40%40H%5D%28O%29%5BC%40%40H%5D%28O%29%5BC%40%40H%5D1N2N%3DC%28C%28N%29%3DO%29N%3DC2'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=OC%5BC%40%40H%5D%28O1%29%5BC%40%40H%5D%28O%29%5BC%40%40H%5D%28O%29%5BC%40%40H%5D1N2N%3DC%28C%28N%29%3DO%29N%3DC2" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Melting point</th><td>166 to 168<span>&nbsp;</span>°C (331 to 334<span>&nbsp;</span>°F)</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">OC[C@@H](O1)[C@@H](O)[C@@H](O)[C@@H]1N2N=C(C(N)=O)N=C2</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:IWUCXVSUMQZMFG-AFCXAGJDSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464382050&page2=Ribavirin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464382050&page2=Ribavirin'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=464382050&page2=Ribavirin" class="external text external">(verify)</a></span></span></td></tr></tbody></table>


<p>Common side effects include feeling tired, headache, nausea, fever, muscle pains, and an irritable mood.<span class="mw-ref" id="cite_ref-AHFS2016_1-6"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Serious side effects include red blood cell breakdown, liver problems, and allergic reactions.<span class="mw-ref" id="cite_ref-AHFS2016_1-7"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Use during pregnancy results in harm to the baby.<span class="mw-ref" id="cite_ref-AHFS2016_1-8"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Effective birth control is recommended for both males and females for at least 7 months during and after use.<span class="mw-ref" id="cite_ref-WHO2008_3-0"><a href="#cite_note-WHO2008-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> The mechanism of action of ribavirin is not entirely clear.<span class="mw-ref" id="cite_ref-AHFS2016_1-9"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


<p>Ribavirin was patented in 1971 and approved for medical use in 1986.<span class="mw-ref" id="cite_ref-4"><a href="#cite_note-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is on the World Health Organization's List of Essential Medicines, the safest and most effective medicines needed in a health system.<span class="mw-ref" id="cite_ref-WHO21st_5-0"><a href="#cite_note-WHO21st-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> It is available as a generic medication.<span class="mw-ref" id="cite_ref-AHFS2016_1-10"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>Ribavirin is used primarily to treat hepatitis C and viral hemorrhagic fevers (which is an orphan indication in most countries).<span class="mw-ref" id="cite_ref-MSR_6-0"><a href="#cite_note-MSR-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> In this former indication the oral (capsule or tablet) form of ribavirin is used in combination with pegylated interferon alfa.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span><span class="mw-ref" id="cite_ref-8"><a href="#cite_note-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span><span class="mw-ref" id="cite_ref-Druyts_961–7_9-0"><a href="#cite_note-Druyts_961–7-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> Including in people coinfected with hepatitis B, HIV and in the pediatric population.<span class="mw-ref" id="cite_ref-Druyts_961–7_9-1"><a href="#cite_note-Druyts_961–7-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span><span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span><span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> Statins may improve this combination's efficacy in treating hepatitis C.<span class="mw-ref" id="cite_ref-13"><a href="#cite_note-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Ribavirin is the only known treatment for a variety of viral hemorrhagic fevers, including Lassa fever, Crimean-Congo hemorrhagic fever, Venezuelan hemorrhagic fever, and Hantavirus infection, although data regarding these infections are scarce and the drug might be effective only in early stages.<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span><span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span><span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-17"><a href="#cite_note-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span> It is noted by the USAMRIID that "Ribavirin has poor in vitro and in vivo activity against the filoviruses (Ebola<span class="mw-ref" id="cite_ref-Goeijenbier2014_18-0"><a href="#cite_note-Goeijenbier2014-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> and Marburg) and the flaviviruses (dengue, yellow fever, Omsk hemorrhagic fever, and Kyasanur forest disease)"<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span> The aerosol form has been used in the past to treat respiratory syncytial virus-related diseases in children, although the evidence to support this is rather weak.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span></p>

<p>It has been used (in combination with <a href="Ketamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Ketamine" title="Ketamine">ketamine</a>, <a href="Midazolam.htm" tppabs="https://ptable.com/wiki/compounds/A/Midazolam" title="Midazolam">midazolam</a>, and <a href="Amantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amantadine" title="Amantadine">amantadine</a>) in treatment of rabies.<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span></p>

<p>Experimental data indicate that ribavirin may have useful activity against canine distemper and poxviruses.<span class="mw-ref" id="cite_ref-Elia2008_22-0"><a href="#cite_note-Elia2008-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span><span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span> Ribavirin has also been used as a treatment for herpes simplex virus. One small study found that ribavirin treatment reduced the severity of herpes outbreaks and promoted recovery, as compared with placebo treatment.<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> Another study found that ribavirin potentiated the antiviral effect of <a href="Aciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Acyclovir" title="Acyclovir" class="mw-redirect">acyclovir</a>.<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span></p>

<p>Some interest has been seen in its possible use as a treatment for cancers, especially acute myeloid leukemia.<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span><span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    


<p>The medication has two FDA "black box" warnings: One raises concerns that use before or during pregnancy by either sex may result in birth defects in the baby, and the other is regarding the risk of red blood cell breakdown.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span></p>

<p>Ribavirin should not be given with <a href="Zidovudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Zidovudine" title="Zidovudine">zidovudine</a> because of the increased risk of anemia;<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span> concurrent use with <a href="Didanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Didanosine" title="Didanosine">didanosine</a> should likewise be avoided because of an increased risk of mitochondrial toxicity.<span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanisms_of_action">Mechanisms of action</h2></summary>
    
<p>It is a <a href="Guanosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanosine" title="Guanosine">guanosine</a> (ribonucleic) analog used to stop viral RNA synthesis and viral mRNA capping, thus, it is a nucleoside inhibitor. Ribavirin is a prodrug, which when metabolized resembles <a href="Purine.htm" tppabs="https://ptable.com/wiki/compounds/A/Purine" title="Purine">purine</a> RNA nucleotides. In this form, it interferes with RNA metabolism required for viral replication. Over five direct and indirect mechanisms have been proposed for its mechanism of action.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="RNA_viruses">RNA viruses</h3></summary>
    
<p>Ribavirin's carboxamide group can make the native nucleoside drug resemble <a href="Adenosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Adenosine" title="Adenosine">adenosine</a> or guanosine, depending on its rotation. For this reason, when ribavirin is incorporated into RNA, as a base analog of either adenine or guanine, it pairs equally well with either uracil or cytosine, inducing mutations in RNA-dependent replication in RNA viruses. Such hypermutation can be lethal to RNA viruses.<span class="mw-ref" id="cite_ref-32"><a href="#cite_note-32" style="counter-reset: mw-Ref 32;"><span class="mw-reflink-text">[32]</span></a></span><span class="mw-ref" id="cite_ref-pmid11907645_33-0"><a href="#cite_note-pmid11907645-33" style="counter-reset: mw-Ref 33;"><span class="mw-reflink-text">[33]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="DNA_viruses">DNA viruses</h3></summary>
    
<p>Neither of these mechanisms explains ribavirin's effect on many DNA viruses, which is more of a mystery, especially given the complete inactivity of ribavirin's 2' deoxyribose analogue, which suggests that the drug functions only as an RNA nucleoside mimic, and never a DNA nucleoside mimic. Ribavirin 5'-monophosphate inhibits cellular inosine monophosphate dehydrogenase, thereby depleting intracellular pools of GTP.<span class="mw-ref" id="cite_ref-pmid16421290_34-0"><a href="#cite_note-pmid16421290-34" style="counter-reset: mw-Ref 34;"><span class="mw-reflink-text">[34]</span></a></span> [ERROR: the cited paper refers only to an RNA virus and so does not support this section's assertion. A reference to a DNA virus is needed here.]</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>Ribavirin was first made in 1972.<span class="mw-ref" id="cite_ref-Sn2001_35-0"><a href="#cite_note-Sn2001-35" style="counter-reset: mw-Ref 35;"><span class="mw-reflink-text">[35]</span></a></span> This was done by researchers from International Chemical and Nuclear Corporation including Joseph T. Witkovski and Roland K. Robins.<span class="mw-ref" id="cite_ref-36"><a href="#cite_note-36" style="counter-reset: mw-Ref 36;"><span class="mw-reflink-text">[36]</span></a></span></p>

<p>It was reported that ribavirin was active against a variety of RNA and DNA viruses in culture and in animals, without undue toxicity.<span class="mw-ref" id="cite_ref-Sidwell1972_37-0"><a href="#cite_note-Sidwell1972-37" style="counter-reset: mw-Ref 37;"><span class="mw-reflink-text">[37]</span></a></span></p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Names">Names</h3></summary>
    
<p>Ribavirin is the INN and USAN, whereas tribavirin is the BAN. Brand names of generic forms include Copegus, Ribasphere, Rebetol.<span class="mw-ref" id="cite_ref-AHFS2016_1-11"><a href="#cite_note-AHFS2016-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Derivatives">Derivatives</h2></summary>
    
<p>Ribavirin is possibly best viewed as a ribosyl purine analogue with an incomplete purine 6-membered ring. This structural resemblance historically prompted replacement of the 2' nitrogen of the triazole with a carbon (which becomes the 5' carbon in an imidazole), in an attempt to partly "fill out" the second ring--- but to no great effect. Such 5' imidazole riboside derivatives show antiviral activity with 5' hydrogen or halide, but the larger the substituent, the smaller the activity, and all proved less active than ribavirin.<span class="mw-ref" id="cite_ref-38"><a href="#cite_note-38" style="counter-reset: mw-Ref 38;"><span class="mw-reflink-text">[38]</span></a></span> Note that two natural products were already known with this imidazole riboside structure: substitution at the 5' carbon with OH results in pyrazofurin, an antibiotic with antiviral properties but unacceptable toxicity, and replacement with an amino group results in the natural purine synthetic precursor 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR), which has only modest antiviral properties.</p>


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Taribavirin">Taribavirin</h3></summary>
    

<p>The most successful ribavirin derivative to date is the 3-carboxamidine derivative of the parent 3-carboxamide, first reported in 1973 by J. T. Witkowski et al.,<span class="mw-ref" id="cite_ref-39"><a href="#cite_note-39" style="counter-reset: mw-Ref 39;"><span class="mw-reflink-text">[39]</span></a></span> and now called taribavirin (former names <i>viramidine</i> and <i>ribamidine</i>). This drug shows a similar spectrum of antiviral activity to ribavirin, which is not surprising as it is now known to be a pro-drug for ribavirin. Taribavirin, however, has useful properties of less erythrocyte-trapping and better liver-targeting than ribavirin. The first property is due to taribavirin's basic amidine group which inhibits drug entry into RBCs, and the second property is probably due to increased concentration of the enzymes which convert amidine to amide in liver tissue.<span class="mw-ref" id="cite_ref-40"><a href="#cite_note-40" style="counter-reset: mw-Ref 40;"><span class="mw-reflink-text">[40]</span></a></span> Taribavirin was in phase III human trials.</p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="See_also">See also</h2></summary>
    
<ul><li>Scavenger system</li>
<li>Favipiravir</li></ul>
<div style="clear:both;"></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-AHFS2016-1"> <span id="mw-reference-text-cite_note-AHFS2016-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/monograph/ribavirin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/ribavirin.html'" tppabs="https://www.drugs.com/monograph/ribavirin.html" class="external text external">"Ribavirin"</a>. The American Society of Health-System Pharmacists. <a href="javascript:if(confirm('https://web.archive.org/web/20161220231037/https://www.drugs.com/monograph/ribavirin.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161220231037/https://www.drugs.com/monograph/ribavirin.html'" tppabs="https://web.archive.org/web/20161220231037/https://www.drugs.com/monograph/ribavirin.html" class="external text external">Archived</a> from the original on 20 December 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">8 December</span> 2016</span>.</cite></span></li><li id="cite_note-TGA-2"> <span id="mw-reference-text-cite_note-TGA-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2012-PI-02077-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2012-PI-02077-3'" tppabs="https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2012-PI-02077-3" class="external text external">"PRODUCT INFORMATION REBETOL® (RIBAVIRIN) CAPSULES"</a> <span class="cs1-format">(PDF)</span>. <i>TGA eBusiness Services</i>. Merck Sharp &amp; Dohme (Australia) Pty Limited. 29 April 2013. <a href="javascript:if(confirm('https://web.archive.org/web/20170816022733/https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2012-PI-02077-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20170816022733/https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2012-PI-02077-3'" tppabs="https://web.archive.org/web/20170816022733/https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent&id=CP-2012-PI-02077-3" class="external text external">Archived</a> from the original on 16 August 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">23 February</span> 2014</span>.</cite></span></li><li id="cite_note-WHO2008-3"> <span id="mw-reference-text-cite_note-WHO2008-3" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2009" class="citation book cs1">World Health Organization (2009).  Stuart MC, Kouimtzi M, Hill SR (eds.). <i>WHO Model Formulary 2008</i>. World Health Organization. p.<span>&nbsp;</span>177. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F44053  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F44053'" tppabs="https://hdl.handle.net/10665%2F44053" class="external text external">10665/44053</a></span>. ISBN<span>&nbsp;</span><bdi>9789241547659</bdi>.</cite></span></li><li id="cite_note-4"> <span id="mw-reference-text-cite_note-4" class="mw-reference-text"><cite id="CITEREFFischerGanellin2006" class="citation book cs1">Fischer, Janos; Ganellin, C. Robin (2006). <a href="javascript:if(confirm('https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA504  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA504'" tppabs="https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA504" class="external text external"><i>Analogue-based Drug Discovery</i></a>. John Wiley &amp; Sons. p.<span>&nbsp;</span>504. ISBN<span>&nbsp;</span><bdi>9783527607495</bdi>. <a href="javascript:if(confirm('https://web.archive.org/web/20161220085929/https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA504  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20161220085929/https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA504'" tppabs="https://web.archive.org/web/20161220085929/https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA504" class="external text external">Archived</a> from the original on 2016-12-20.</cite></span></li><li id="cite_note-WHO21st-5"> <span id="mw-reference-text-cite_note-WHO21st-5" class="mw-reference-text"><cite id="CITEREFWorld_Health_Organization2019" class="citation book cs1">World Health Organization (2019). <i>World Health Organization model list of essential medicines: 21st list 2019</i>. Geneva: World Health Organization. hdl:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://hdl.handle.net/10665%2F325771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://hdl.handle.net/10665%2F325771'" tppabs="https://hdl.handle.net/10665%2F325771" class="external text external">10665/325771</a></span>. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.</cite></span></li><li id="cite_note-MSR-6"> <span id="mw-reference-text-cite_note-MSR-6" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://reference.medscape.com/drug/rebetol-ribasphere-ribavirin-342625  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://reference.medscape.com/drug/rebetol-ribasphere-ribavirin-342625#showall'" tppabs="http://reference.medscape.com/drug/rebetol-ribasphere-ribavirin-342625#showall" class="external text external">"Rebetol, Ribasphere (ribavirin) dosing, indications, interactions, adverse effects, and more"</a>. <i>Medscape Reference</i>. WebMD. <a href="javascript:if(confirm('https://web.archive.org/web/20140228132755/http://reference.medscape.com/drug/rebetol-ribasphere-ribavirin-342625  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140228132755/http://reference.medscape.com/drug/rebetol-ribasphere-ribavirin-342625#showall'" tppabs="https://web.archive.org/web/20140228132755/http://reference.medscape.com/drug/rebetol-ribasphere-ribavirin-342625#showall" class="external text external">Archived</a> from the original on 28 February 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">23 February</span> 2014</span>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFPaeshuyseDallmeierNeyts2011" class="citation journal cs1">Paeshuyse J, Dallmeier K, Neyts J (December 2011). "Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action". <i>Current Opinion in Virology</i>. <b>1</b> (6): 590–8. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.coviro.2011.10.030  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.coviro.2011.10.030'" tppabs="https://doi.org/10.1016%2Fj.coviro.2011.10.030" class="external text external">10.1016/j.coviro.2011.10.030</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22440916  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22440916'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22440916" class="external text external">22440916</a>.</cite></span></li><li id="cite_note-8"> <span id="mw-reference-text-cite_note-8" class="mw-reference-text"><cite id="CITEREFFloriFunakoshiDunyValats2013" class="citation journal cs1">Flori N, Funakoshi N, Duny Y, Valats JC, Bismuth M, Christophorou D, Daurès JP, Blanc P (March 2013). "Pegylated interferon-α2a and ribavirin versus pegylated interferon-α2b and ribavirin in chronic hepatitis C<span>&nbsp;</span>: a meta-analysis". <i>Drugs</i>. <b>73</b> (3): 263–77. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs40265-013-0027-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs40265-013-0027-1'" tppabs="https://doi.org/10.1007%2Fs40265-013-0027-1" class="external text external">10.1007/s40265-013-0027-1</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23436591  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23436591'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23436591" class="external text external">23436591</a>.</cite></span></li><li id="cite_note-Druyts_961–7-9"> <span id="mw-reference-text-cite_note-Druyts_961–7-9" class="mw-reference-text"><cite id="CITEREFDruytsThorlundWuKanters2013" class="citation journal cs1">Druyts E, Thorlund K, Wu P, Kanters S, Yaya S, Cooper CL, Mills EJ (April 2013). <a href="javascript:if(confirm('https://doi.org/10.1093/cid/cis1031  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093/cid/cis1031'" tppabs="https://doi.org/10.1093/cid/cis1031" class="external text external">"Efficacy and safety of pegylated interferon alfa-2a or alfa-2b plus ribavirin for the treatment of chronic hepatitis C in children and adolescents: a systematic review and meta-analysis"</a>. <i>Clinical Infectious Diseases</i>. <b>56</b> (7): 961–7. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fcid%2Fcis1031  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fcid%2Fcis1031'" tppabs="https://doi.org/10.1093%2Fcid%2Fcis1031" class="external text external">10.1093/cid/cis1031</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23243171  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23243171'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23243171" class="external text external">23243171</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFZeuzemPoordad2010" class="citation journal cs1">Zeuzem S, Poordad F (July 2010). "Pegylated-interferon plus ribavirin therapy in the treatment of CHC: individualization of treatment duration according to on-treatment virologic response". <i>Current Medical Research and Opinion</i>. <b>26</b> (7): 1733–43. doi:<a href="javascript:if(confirm('https://doi.org/10.1185%2F03007995.2010.487038  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1185%2F03007995.2010.487038'" tppabs="https://doi.org/10.1185%2F03007995.2010.487038" class="external text external">10.1185/03007995.2010.487038</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20482242  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20482242'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20482242" class="external text external">20482242</a>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFLiuShengHuZhong2012" class="citation journal cs1">Liu JY, Sheng YJ, Hu HD, Zhong Q, Wang J, Tong SW, Zhou Z, Zhang DZ, Hu P, Ren H (September 2012). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511228  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511228'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511228" class="external text external">"The influence of hepatitis B virus on antiviral treatment with interferon and ribavirin in Asian patients with hepatitis C virus/hepatitis B virus coinfection: a meta-analysis"</a>. <i>Virology Journal</i>. <b>9</b>: 186. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2F1743-422X-9-186  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1743-422X-9-186'" tppabs="https://doi.org/10.1186%2F1743-422X-9-186" class="external text external">10.1186/1743-422X-9-186</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511228  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511228'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511228" class="external text external">3511228</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/22950520  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/22950520'" tppabs="https://pubmed.ncbi.nlm.nih.gov/22950520" class="external text external">22950520</a>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFBassoParisiMengoliGentilini2013" class="citation journal cs1">Basso M, Parisi SG, Mengoli C, Gentilini V, Menegotto N, Monticelli J, Nicolè S, Cruciani M, Palù G (July–August 2013). "Sustained virological response and baseline predictors in HIV-HCV coinfected patients retreated with pegylated interferon and ribavirin after failing a previous interferon-based therapy: systematic review and meta-analysis". <i>HIV Clinical Trials</i>. <b>14</b> (4): 127–39. doi:<a href="javascript:if(confirm('https://doi.org/10.1310%2Fhct1404-127  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1310%2Fhct1404-127'" tppabs="https://doi.org/10.1310%2Fhct1404-127" class="external text external">10.1310/hct1404-127</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23924585  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23924585'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23924585" class="external text external">23924585</a>.</cite></span></li><li id="cite_note-13"> <span id="mw-reference-text-cite_note-13" class="mw-reference-text"><cite id="CITEREFZhuLiHanZhang2013" class="citation journal cs1">Zhu Q, Li N, Han Q, Zhang P, Yang C, Zeng X, Chen Y, Lv Y, Liu X, Liu Z (June 2013). "Statin therapy improves response to interferon alfa and ribavirin in chronic hepatitis C: a systematic review and meta-analysis". <i>Antiviral Research</i>. <b>98</b> (3): 373–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.antiviral.2013.04.009  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.antiviral.2013.04.009'" tppabs="https://doi.org/10.1016%2Fj.antiviral.2013.04.009" class="external text external">10.1016/j.antiviral.2013.04.009</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23603497  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23603497'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23603497" class="external text external">23603497</a>.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite class="citation book cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20110929151854/http://www.rki.de/cln_091/nn_468470/DE/Content/InfAZ/Steckbriefe/Steckbriefe__120606%2CtemplateId%3Draw%2Cproperty%3DpublicationFile.pdf/Steckbriefe_120606.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20110929151854/http://www.rki.de/cln_091/nn_468470/DE/Content/InfAZ/Steckbriefe/Steckbriefe__120606%2CtemplateId%3Draw%2Cproperty%3DpublicationFile.pdf/Steckbriefe_120606.pdf'" tppabs="https://web.archive.org/web/20110929151854/http://www.rki.de/cln_091/nn_468470/DE/Content/InfAZ/Steckbriefe/Steckbriefe__120606%2CtemplateId%3Draw%2Cproperty%3DpublicationFile.pdf/Steckbriefe_120606.pdf" class="external text external"><i>Steckbriefe seltener und importierter Infektionskrankheiten</i></a> <span>[</span><i>Characteristics of rare and imported infectious diseases</i><span>]</span> <span class="cs1-format">(PDF)</span>. Berlin: Robert Koch Institute. 2006. ISBN<span>&nbsp;</span><bdi>978-3-89606-095-2</bdi>. Archived from <a href="javascript:if(confirm('http://www.rki.de/cln_091/nn_468470/DE/Content/InfAZ/Steckbriefe/Steckbriefe__120606,templateId=raw,property=publicationFile.pdf/Steckbriefe_120606.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rki.de/cln_091/nn_468470/DE/Content/InfAZ/Steckbriefe/Steckbriefe__120606,templateId=raw,property=publicationFile.pdf/Steckbriefe_120606.pdf'" tppabs="http://www.rki.de/cln_091/nn_468470/DE/Content/InfAZ/Steckbriefe/Steckbriefe__120606,templateId=raw,property=publicationFile.pdf/Steckbriefe_120606.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2011-09-29.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFAsciogluLeblebiciogluVahabogluChan2011" class="citation journal cs1">Ascioglu S, Leblebicioglu H, Vahaboglu H, Chan KA (June 2011). <a href="javascript:if(confirm('http://jac.oxfordjournals.org/content/66/6/1215.full.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://jac.oxfordjournals.org/content/66/6/1215.full.pdf'" tppabs="http://jac.oxfordjournals.org/content/66/6/1215.full.pdf" class="external text external">"Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis"</a> <span class="cs1-format">(PDF)</span>. <i>The Journal of Antimicrobial Chemotherapy</i>. <b>66</b> (6): 1215–22. doi:<a href="javascript:if(confirm('https://doi.org/10.1093%2Fjac%2Fdkr136  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fjac%2Fdkr136'" tppabs="https://doi.org/10.1093%2Fjac%2Fdkr136" class="external text external">10.1093/jac/dkr136</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21482564  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21482564'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21482564" class="external text external">21482564</a>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite id="CITEREFBauschHadiKhanLertora2010" class="citation journal cs1">Bausch DG, Hadi CM, Khan SH, Lertora JJ (December 2010). <a href="javascript:if(confirm('http://cid.oxfordjournals.org/content/51/12/1435.full.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://cid.oxfordjournals.org/content/51/12/1435.full.pdf'" tppabs="http://cid.oxfordjournals.org/content/51/12/1435.full.pdf" class="external text external">"Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever"</a> <span class="cs1-format">(PDF)</span>. <i>Clinical Infectious Diseases</i>. <b>51</b> (12): 1435–41. doi:<a href="javascript:if(confirm('https://doi.org/10.1086%2F657315  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1086%2F657315'" tppabs="https://doi.org/10.1086%2F657315" class="external text external">10.1086/657315</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21058912  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21058912'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21058912" class="external text external">21058912</a>.</cite></span></li><li id="cite_note-17"> <span id="mw-reference-text-cite_note-17" class="mw-reference-text"><cite id="CITEREFSoares-WeiserThomasThomsonGarner2010" class="citation journal cs1">Soares-Weiser K, Thomas S, Thomson G, Garner P (July 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912908  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912908'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912908" class="external text external">"Ribavirin for Crimean-Congo hemorrhagic fever: systematic review and meta-analysis"</a>. <i>BMC Infectious Diseases</i>. <b>10</b>: 207. doi:<a href="javascript:if(confirm('https://doi.org/10.1186%2F1471-2334-10-207  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1186%2F1471-2334-10-207'" tppabs="https://doi.org/10.1186%2F1471-2334-10-207" class="external text external">10.1186/1471-2334-10-207</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912908  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912908'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912908" class="external text external">2912908</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20626907  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20626907'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20626907" class="external text external">20626907</a>.</cite></span></li><li id="cite_note-Goeijenbier2014-18"> <span id="mw-reference-text-cite_note-Goeijenbier2014-18" class="mw-reference-text"><cite id="CITEREFGoeijenbiervan_KampenReuskenKoopmans2014" class="citation journal cs1">Goeijenbier M, van Kampen JJ, Reusken CB, Koopmans MP, van Gorp EC (November 2014). <a href="javascript:if(confirm('http://www.njmonline.nl/getpdf.php?t=a&id=10001148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.njmonline.nl/getpdf.php?t=a&id=10001148'" tppabs="http://www.njmonline.nl/getpdf.php?t=a&id=10001148" class="external text external">"Ebola virus disease: a review on epidemiology, symptoms, treatment and pathogenesis"</a>. <i>The Netherlands Journal of Medicine</i>. <b>72</b> (9): 442–8. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25387613  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25387613'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25387613" class="external text external">25387613</a>. <a href="javascript:if(confirm('https://web.archive.org/web/20141129144852/http://www.njmonline.nl/getpdf.php?t=a&id=10001148  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20141129144852/http://www.njmonline.nl/getpdf.php?t=a&id=10001148'" tppabs="https://web.archive.org/web/20141129144852/http://www.njmonline.nl/getpdf.php?t=a&id=10001148" class="external text external">Archived</a> from the original on 2014-11-29.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite class="citation book cs1"><i>Medical Management of Biological Casualties Handbook</i>. United States Government Printing Office. 2011. p.<span>&nbsp;</span>115. ISBN<span>&nbsp;</span><bdi>978-0-16-090015-0</bdi>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFVentreRandolph2007" class="citation journal cs1">Ventre K, Randolph AG (January 2007). "Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children". <i>The Cochrane Database of Systematic Reviews</i> (1): CD000181. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2F14651858.CD000181.pub3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2F14651858.CD000181.pub3'" tppabs="https://doi.org/10.1002%2F14651858.CD000181.pub3" class="external text external">10.1002/14651858.CD000181.pub3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17253446  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17253446'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17253446" class="external text external">17253446</a>.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFHemachudhaUgoliniWacharapluesadeeSungkarat2013" class="citation journal cs1">Hemachudha T, Ugolini G, Wacharapluesadee S, Sungkarat W, Shuangshoti S, Laothamatas J (May 2013). "Human rabies: neuropathogenesis, diagnosis, and management". <i>The Lancet. Neurology</i>. <b>12</b> (5): 498–513. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS1474-4422%2813%2970038-3  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1474-4422%2813%2970038-3'" tppabs="https://doi.org/10.1016%2FS1474-4422%2813%2970038-3" class="external text external">10.1016/S1474-4422(13)70038-3</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23602163  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23602163'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23602163" class="external text external">23602163</a>.</cite></span></li><li id="cite_note-Elia2008-22"> <span id="mw-reference-text-cite_note-Elia2008-22" class="mw-reference-text"><cite id="CITEREFEliaBelloliCironeLucente2008" class="citation journal cs1">Elia G, Belloli C, Cirone F, Lucente MS, Caruso M, Martella V, Decaro N, Buonavoglia C, Ormas P (February 2008). "In vitro efficacy of ribavirin against canine distemper virus". <i>Antiviral Research</i>. <b>77</b> (2): 108–13. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.antiviral.2007.09.004  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.antiviral.2007.09.004'" tppabs="https://doi.org/10.1016%2Fj.antiviral.2007.09.004" class="external text external">10.1016/j.antiviral.2007.09.004</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17949825  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17949825'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17949825" class="external text external">17949825</a>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite id="CITEREFBakerBrayHuggins2003" class="citation journal cs1">Baker, Robert O.; Bray, Mike; Huggins, John W. (January 2003). "Potential antiviral therapeutics for smallpox, monkeypox and other orthopoxvirus infections". <i>Antiviral Research</i>. <b>57</b> (1–2): 13–23. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0166-3542%2802%2900196-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0166-3542%2802%2900196-1'" tppabs="https://doi.org/10.1016%2FS0166-3542%2802%2900196-1" class="external text external">10.1016/S0166-3542(02)00196-1</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0166-3542  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0166-3542'" tppabs="https://www.worldcat.org/issn/0166-3542" class="external text external">0166-3542</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12615299  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12615299'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12615299" class="external text external">12615299</a>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite id="CITEREFBiermanKirkpatrickFernandez1981" class="citation journal cs1">Bierman SM, Kirkpatrick W, Fernandez H (1981). "Clinical efficacy of ribavirin in the treatment of genital herpes simplex virus infection". <i>Chemotherapy</i>. <b>27</b> (2): 139–45. doi:<a href="javascript:if(confirm('https://doi.org/10.1159%2F000237969  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1159%2F000237969'" tppabs="https://doi.org/10.1159%2F000237969" class="external text external">10.1159/000237969</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7009087  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7009087'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7009087" class="external text external">7009087</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFPancheva1991" class="citation journal cs1">Pancheva SN (September 1991). "Potentiating effect of ribavirin on the anti-herpes activity of acyclovir". <i>Antiviral Research</i>. <b>16</b> (2): 151–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0166-3542%2891%2990021-I  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0166-3542%2891%2990021-I'" tppabs="https://doi.org/10.1016%2F0166-3542%2891%2990021-I" class="external text external">10.1016/0166-3542(91)90021-I</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/1665959  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/1665959'" tppabs="https://pubmed.ncbi.nlm.nih.gov/1665959" class="external text external">1665959</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFKast2002" class="citation journal cs1">Kast RE (November–December 2002). <a href="javascript:if(confirm('https://web.archive.org/web/20140228124717/https://www.landesbioscience.com/journals/cbt/kast1-6.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20140228124717/https://www.landesbioscience.com/journals/cbt/kast1-6.pdf'" tppabs="https://web.archive.org/web/20140228124717/https://www.landesbioscience.com/journals/cbt/kast1-6.pdf" class="external text external">"Ribavirin in cancer immunotherapies: controlling nitric oxide helps generate cytotoxic lymphocyte"</a> <span class="cs1-format">(PDF)</span>. <i>Cancer Biology &amp; Therapy</i>. <b>1</b> (6): 626–30. doi:<a href="javascript:if(confirm('https://doi.org/10.4161%2Fcbt.310  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.4161%2Fcbt.310'" tppabs="https://doi.org/10.4161%2Fcbt.310" class="external text external">10.4161/cbt.310</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/12642684  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/12642684'" tppabs="https://pubmed.ncbi.nlm.nih.gov/12642684" class="external text external">12642684</a>. Archived from <a href="javascript:if(confirm('https://www.landesbioscience.com/journals/cbt/kast1-6.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.landesbioscience.com/journals/cbt/kast1-6.pdf'" tppabs="https://www.landesbioscience.com/journals/cbt/kast1-6.pdf" class="external text external">the original</a> <span class="cs1-format">(PDF)</span> on 2014-02-28.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFBordenCuljkovic-Kraljacic2010" class="citation journal cs1">Borden KL, Culjkovic-Kraljacic B (October 2010). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950216  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950216'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950216" class="external text external">"Ribavirin as an anti-cancer therapy: acute myeloid leukemia and beyond?"</a>. <i>Leukemia &amp; Lymphoma</i>. <b>51</b> (10): 1805–15. doi:<a href="javascript:if(confirm('https://doi.org/10.3109%2F10428194.2010.496506  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3109%2F10428194.2010.496506'" tppabs="https://doi.org/10.3109%2F10428194.2010.496506" class="external text external">10.3109/10428194.2010.496506</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950216  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950216'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950216" class="external text external">2950216</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20629523  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20629523'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20629523" class="external text external">20629523</a>.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021511s023lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021511s023lbl.pdf'" tppabs="http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021511s023lbl.pdf" class="external text external">"Copedgus"</a> <span class="cs1-format">(PDF)</span>. <i>FDA.gov</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20141103185016/http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021511s023lbl.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20141103185016/http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021511s023lbl.pdf'" tppabs="https://web.archive.org/web/20141103185016/http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021511s023lbl.pdf" class="external text external">Archived</a> <span class="cs1-format">(PDF)</span> from the original on 3 November 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">16 April</span> 2017</span>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFAlvarezDieterichBrauMoorehead2006" class="citation journal cs1">Alvarez D, Dieterich DT, Brau N, Moorehead L, Ball L, Sulkowski MS (October 2006). "Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons". <i>Journal of Viral Hepatitis</i>. <b>13</b> (10): 683–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1365-2893.2006.00749.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1365-2893.2006.00749.x'" tppabs="https://doi.org/10.1111%2Fj.1365-2893.2006.00749.x" class="external text external">10.1111/j.1365-2893.2006.00749.x</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16970600  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16970600'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16970600" class="external text external">16970600</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite id="CITEREFBani-SadrCarratPolHor2005" class="citation journal cs1">Bani-Sadr F, Carrat F, Pol S, Hor R, Rosenthal E, Goujard C, Morand P, Lunel-Fabiani F, Salmon-Ceron D, Piroth L, Pialoux G, Bentata M, Cacoub P, Perronne C (September 2005). "Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy". <i>Journal of Acquired Immune Deficiency Syndromes</i>. <b>40</b> (1): 47–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1097%2F01.qai.0000174649.51084.46  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1097%2F01.qai.0000174649.51084.46'" tppabs="https://doi.org/10.1097%2F01.qai.0000174649.51084.46" class="external text external">10.1097/01.qai.0000174649.51084.46</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16123681  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16123681'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16123681" class="external text external">16123681</a>.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFGraciCameron2006" class="citation journal cs1">Graci JD, Cameron CE (January 2006). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169142  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169142'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169142" class="external text external">"Mechanisms of action of ribavirin against distinct viruses"</a>. <i>Reviews in Medical Virology</i>. <b>16</b> (1): 37–48. doi:<a href="javascript:if(confirm('https://doi.org/10.1002%2Frmv.483  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1002%2Frmv.483'" tppabs="https://doi.org/10.1002%2Frmv.483" class="external text external">10.1002/rmv.483</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169142  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169142'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7169142" class="external text external">7169142</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16287208  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16287208'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16287208" class="external text external">16287208</a>.</cite></span></li><li id="cite_note-32"> <span id="mw-reference-text-cite_note-32" class="mw-reference-text"><cite id="CITEREFOrtega-PrietoSheldonGrande-PérezTejero2013" class="citation journal cs1">Ortega-Prieto AM, Sheldon J, Grande-Pérez A, Tejero H, Gregori J, Quer J, Esteban JI, Domingo E, Perales C (2013).  Vartanian J (ed.). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745404  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745404'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745404" class="external text external">"Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis"</a>. <i>PLoS One</i>. <b>8</b> (8): e71039. doi:<a href="javascript:if(confirm('https://doi.org/10.1371%2Fjournal.pone.0071039  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1371%2Fjournal.pone.0071039'" tppabs="https://doi.org/10.1371%2Fjournal.pone.0071039" class="external text external">10.1371/journal.pone.0071039</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745404  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745404'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745404" class="external text external">3745404</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/23976977  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/23976977'" tppabs="https://pubmed.ncbi.nlm.nih.gov/23976977" class="external text external">23976977</a>.</cite></span></li><li id="cite_note-pmid11907645-33"> <span id="mw-reference-text-cite_note-pmid11907645-33" class="mw-reference-text"><cite id="CITEREFCrottyCameronAndino2002" class="citation journal cs1">Crotty S, Cameron C, Andino R (February 2002). "Ribavirin's antiviral mechanism of action: lethal mutagenesis?". <i>Journal of Molecular Medicine</i>. <b>80</b> (2): 86–95. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs00109-001-0308-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs00109-001-0308-0'" tppabs="https://doi.org/10.1007%2Fs00109-001-0308-0" class="external text external">10.1007/s00109-001-0308-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11907645  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11907645'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11907645" class="external text external">11907645</a>.</cite></span></li><li id="cite_note-pmid16421290-34"> <span id="mw-reference-text-cite_note-pmid16421290-34" class="mw-reference-text"><cite id="CITEREFLeyssenDe_ClercqNeyts2006" class="citation journal cs1">Leyssen P, De Clercq E, Neyts J (April 2006). "The anti-yellow fever virus activity of ribavirin is independent of error-prone replication". <i>Molecular Pharmacology</i>. <b>69</b> (4): 1461–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1124%2Fmol.105.020057  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1124%2Fmol.105.020057'" tppabs="https://doi.org/10.1124%2Fmol.105.020057" class="external text external">10.1124/mol.105.020057</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16421290  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16421290'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16421290" class="external text external">16421290</a>.</cite></span></li><li id="cite_note-Sn2001-35"> <span id="mw-reference-text-cite_note-Sn2001-35" class="mw-reference-text"><cite id="CITEREFSnell2001" class="citation journal cs1">Snell NJ (August 2001). "Ribavirin--current status of a broad spectrum antiviral agent". <i>Expert Opinion on Pharmacotherapy</i>. <b>2</b> (8): 1317–24. doi:<a href="javascript:if(confirm('https://doi.org/10.1517%2F14656566.2.8.1317  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1517%2F14656566.2.8.1317'" tppabs="https://doi.org/10.1517%2F14656566.2.8.1317" class="external text external">10.1517/14656566.2.8.1317</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11585000  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11585000'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11585000" class="external text external">11585000</a>.</cite></span></li><li id="cite_note-36"> <span id="mw-reference-text-cite_note-36" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://www.news-medical.net/health/Ribavirin-History.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.news-medical.net/health/Ribavirin-History.aspx'" tppabs="http://www.news-medical.net/health/Ribavirin-History.aspx" class="external text external">"Ribavirin History"</a>. <i>News-Medical.net</i>. <a href="javascript:if(confirm('https://web.archive.org/web/20160302004242/http://www.news-medical.net/health/Ribavirin-History.aspx  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20160302004242/http://www.news-medical.net/health/Ribavirin-History.aspx'" tppabs="https://web.archive.org/web/20160302004242/http://www.news-medical.net/health/Ribavirin-History.aspx" class="external text external">Archived</a> from the original on 2016-03-02<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-02-19</span></span>.</cite></span></li><li id="cite_note-Sidwell1972-37"> <span id="mw-reference-text-cite_note-Sidwell1972-37" class="mw-reference-text"><cite id="CITEREFSidwellHuffmanKhareAllen1972" class="citation journal cs1">Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT, Robins RK (August 1972). "Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide". <i>Science</i>. <b>177</b> (4050): 705–6. doi:<a href="javascript:if(confirm('https://doi.org/10.1126%2Fscience.177.4050.705  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1126%2Fscience.177.4050.705'" tppabs="https://doi.org/10.1126%2Fscience.177.4050.705" class="external text external">10.1126/science.177.4050.705</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4340949  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4340949'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4340949" class="external text external">4340949</a>.</cite></span></li><li id="cite_note-38"> <span id="mw-reference-text-cite_note-38" class="mw-reference-text"><cite id="CITEREFSmith_RA_&amp;_Kirkpatrick_W_(eds.)1980" class="citation book cs1">Smith RA <span>&amp;</span> Kirkpatrick W (eds.) (1980). "Ribavirin: structure and antiviral activity relationships". <i>Ribavirin: A Broad Spectrum Antiviral Agent</i>. New York: Academic Press. pp.<span>&nbsp;</span>1–21.</cite><span class="cs1-maint citation-comment">CS1 maint: extra text: authors list (link)</span></span></li><li id="cite_note-39"> <span id="mw-reference-text-cite_note-39" class="mw-reference-text"><cite id="CITEREFWitkowskiRobinsKhareSidwell1973" class="citation journal cs1">Witkowski JT, Robins RK, Khare GP, Sidwell RW (August 1973). "Synthesis and antiviral activity of 1,2,4-triazole-3-thiocarboxamide and 1,2,4-triazole-3-carboxamidine ribonucleosides". <i>Journal of Medicinal Chemistry</i>. <b>16</b> (8): 935–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1021%2Fjm00266a014  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1021%2Fjm00266a014'" tppabs="https://doi.org/10.1021%2Fjm00266a014" class="external text external">10.1021/jm00266a014</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4355593  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4355593'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4355593" class="external text external">4355593</a>.</cite></span></li><li id="cite_note-40"> <span id="mw-reference-text-cite_note-40" class="mw-reference-text"><cite id="CITEREFSidwellBaileyWongBarnard2005" class="citation journal cs1">Sidwell RW, Bailey KW, Wong MH, Barnard DL, Smee DF (October 2005). "In vitro and in vivo influenza virus-inhibitory effects of viramidine". <i>Antiviral Research</i>. <b>68</b> (1): 10–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.antiviral.2005.06.003  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.antiviral.2005.06.003'" tppabs="https://doi.org/10.1016%2Fj.antiviral.2005.06.003" class="external text external">10.1016/j.antiviral.2005.06.003</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16087250  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16087250'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16087250" class="external text external">16087250</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/ribavirin  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/ribavirin'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/ribavirin" class="external text external">"Ribavirin"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="DNA_virus_antivirals_(primarily_J05,_also_S01AD_and_D06BB)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="DNA_virus_antivirals_(primarily_J05,_also_S01AD_and_D06BB)" style="font-size:114%;margin:0 4em">DNA virus antivirals (primarily J05, also S01AD and D06BB)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Baltimore I</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Herpesvirus</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">DNA-synthesis<br>inhibitor</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">TK activated</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Purine analogue</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i><a href="Guanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanine" title="Guanine">guanine</a></i> (<a href="Aciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Aciclovir" title="Aciclovir">Aciclovir</a><sup>#</sup>/<a href="Valaciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Valaciclovir" title="Valaciclovir">Valaciclovir</a></li>
<li><a href="Ganciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Ganciclovir" title="Ganciclovir">Ganciclovir</a>/<a href="Valganciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Valganciclovir" title="Valganciclovir">Valganciclovir</a><sup>#</sup></li>
<li><a href="Penciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Penciclovir" title="Penciclovir">Penciclovir</a>/<a href="Famciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Famciclovir" title="Famciclovir">Famciclovir</a>)</li></ul>

<ul><li><i><a href="Adenine.htm" tppabs="https://ptable.com/wiki/compounds/A/Adenine" title="Adenine">adenine</a></i> (<a href="Vidarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vidarabine" title="Vidarabine">Vidarabine</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pyrimidine analogue</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i><a href="Uridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Uridine" title="Uridine">uridine</a></i> (<a href="Idoxuridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Idoxuridine" title="Idoxuridine">Idoxuridine</a></li>
<li><a href="Trifluridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Trifluridine" title="Trifluridine">Trifluridine</a> (+tipiracil)</li>
<li><a href="Edoxudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Edoxudine" title="Edoxudine">Edoxudine</a>)</li></ul>

<ul><li><i><a href="Thymine.htm" tppabs="https://ptable.com/wiki/compounds/A/Thymine" title="Thymine">thymine</a></i>
<ul><li>Brivudine</li>
<li>FV-100<sup>†</sup></li>
<li>Sorivudine</li></ul></li></ul>

<ul><li><i><a href="Cytosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytosine" title="Cytosine">cytosine</a></i> (<a href="Cytarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytarabine" title="Cytarabine">Cytarabine</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Not TK activated</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Foscarnet.htm" tppabs="https://ptable.com/wiki/compounds/A/Foscarnet" title="Foscarnet">Foscarnet</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Docosanol.htm" tppabs="https://ptable.com/wiki/compounds/A/Docosanol" title="Docosanol">Docosanol</a></li>
<li>Maribavir<sup>†</sup></li>
<li><i>early protein</i> (Fomivirsen)</li>
<li>Tromantadine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">HPV/MC</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Imiquimod.htm" tppabs="https://ptable.com/wiki/compounds/A/Imiquimod" title="Imiquimod">Imiquimod</a>/Resiquimod</li>
<li><a href="Podophyllotoxin.htm" tppabs="https://ptable.com/wiki/compounds/A/Podophyllotoxin" title="Podophyllotoxin">Podophyllotoxin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Vaccinia</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>assembly:</i> <a href="Rifampicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Rifampicin" title="Rifampicin">Rifampicin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Poxviridae</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Methisazone.htm" tppabs="https://ptable.com/wiki/compounds/A/Methisazone" title="Methisazone" class="mw-redirect">Methisazone</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Hepatitis B (VII)</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nucleoside analogues/NARTIs:</i> <a href="Entecavir.htm" tppabs="https://ptable.com/wiki/compounds/A/Entecavir" title="Entecavir">Entecavir</a><sup>#</sup></li>
<li><a href="Lamivudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lamivudine" title="Lamivudine">Lamivudine</a></li>
<li>Lobucavir<sup>†</sup></li>
<li><a href="Telbivudine.htm" tppabs="https://ptable.com/wiki/compounds/A/Telbivudine" title="Telbivudine">Telbivudine</a></li>
<li>Clevudine</li></ul>

<ul><li><i>Nucleotide analogues/NtRTIs:</i> <a href="Adefovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Adefovir" title="Adefovir">Adefovir</a></li>
<li>Tenofovir disoproxil</li>
<li>Tenofovir alafenamide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Multiple/general</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Nucleic acid inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Cidofovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Cidofovir" title="Cidofovir">Cidofovir</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Interferon</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Interferon alfa 2b</li>
<li>Peginterferon alfa-2a</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Multiple/unknown</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Filociclovir<sup>†</sup></li>
<li><a href="Ribavirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ribavirin" title="Ribavirin">Ribavirin</a><sup>#</sup>/Taribavirin<sup><b>†</b></sup></li>
<li>Moroxydine</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="RNA_virus_antivirals_(primarily_J05,_also_S01AD_and_D06BB)" style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="RNA_virus_antivirals_(primarily_J05,_also_S01AD_and_D06BB)" style="font-size:114%;margin:0 4em">RNA virus antivirals (primarily J05, also S01AD and D06BB)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Hepatitis C</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">NS3/4A protease inhibitors (–previr)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Asunaprevir</li>
<li>Boceprevir<sup><b>‡</b></sup></li>
<li>Ciluprevir<sup><b>§</b></sup></li>
<li>Danoprevir<sup><b>†</b></sup></li>
<li>Faldaprevir<sup><b>‡</b></sup></li>
<li>Glecaprevir</li>
<li>Grazoprevir</li>
<li>Narlaprevir</li>
<li>Paritaprevir</li>
<li>Simeprevir</li>
<li>Sovaprevir<sup><b>†</b></sup></li>
<li>Telaprevir<sup><b>‡</b></sup></li>
<li>Vaniprevir</li>
<li><span class="new">Vedroprevir</span><sup><b>§</b></sup></li>
<li>Voxilaprevir</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">NS5A inhibitors (–asvir)</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Daclatasvir<sup><b>#</b></sup></li>
<li>Elbasvir</li>
<li>Ledipasvir</li>
<li>Odalasvir<sup><b>†</b></sup></li>
<li>Ombitasvir</li>
<li>Pibrentasvir</li>
<li>Ravidasvir<sup><b>†</b></sup></li>
<li><span class="new">Ruzasvir</span><sup><b>†</b></sup></li>
<li>Samatasvir<sup><b>†</b></sup></li>
<li>Velpatasvir</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">NS5B RNA polymerase inhibitors (–buvir)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Beclabuvir<sup><b>†</b></sup></li>
<li>Dasabuvir<sup><b>#</b></sup></li>
<li>Deleobuvir<sup><b>§</b></sup></li>
<li>Filibuvir<sup><b>§</b></sup></li>
<li>GS-6620<sup><b>§</b></sup></li>
<li>IDX-184<sup><b>§</b></sup></li>
<li>Setrobuvir<sup><b>§</b></sup></li>
<li>Sofosbuvir<sup><b>#</b></sup></li>
<li><span class="new">Tegobuvir</span><sup><b>§</b></sup></li>
<li>TMC-647055<sup><b>§</b></sup></li>
<li>Radalbuvir<sup><b>†</b></sup></li>
<li>Uprifosbuvir<sup><b>†</b></sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Combination drugs</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Elbasvir/grazoprevir</li>
<li>Glecaprevir/pibrentasvir</li>
<li>Ledipasvir/sofosbuvir<sup><b>#</b></sup></li>
<li>Ombitasvir/paritaprevir/ritonavir<sup><b>#</b></sup></li>
<li>Sofosbuvir/daclatasvir</li>
<li>Sofosbuvir/velpatasvir<sup><b>#</b></sup></li>
<li>Sofosbuvir/velpatasvir/voxilaprevir</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Hepatitis D</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Bulevirtide</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Picornavirus</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>viral entry:</i> Pleconaril<sup><b>†</b></sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Anti-influenza agents</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Baloxavir marboxil</li>
<li>Pimodivir<sup><b>†</b></sup></li>
<li>Umifenovir</li></ul>

<ul><li><i><a href="Adamantane.htm" tppabs="https://ptable.com/wiki/compounds/A/Adamantane" title="Adamantane">adamantane derivatives</a>/M2 inhibitors</i> (Adapromine</li>
<li><a href="Amantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amantadine" title="Amantadine">Amantadine</a></li>
<li><a href="Rimantadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Rimantadine" title="Rimantadine">Rimantadine</a>)</li></ul>

<ul><li><i>neuraminidase inhibitors/release phase</i> (<a href="Oseltamivir.htm" tppabs="https://ptable.com/wiki/compounds/A/Oseltamivir" title="Oseltamivir">Oseltamivir</a><sup><b>#</b></sup></li>
<li><a href="Zanamivir.htm" tppabs="https://ptable.com/wiki/compounds/A/Zanamivir" title="Zanamivir">Zanamivir</a></li>
<li>Peramivir, Laninamivir<sup><b>†</b></sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Multiple/general</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Interferon</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Interferon alfa 2b</li>
<li>Peginterferon alfa-2a<sup><b>#</b></sup></li>
<li>Peginterferon alfa-2b<sup><b>#</b></sup></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Multiple/unknown</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>CMX521<sup><b>§</b></sup></li>
<li>EICAR<sup><b>§</b></sup></li>
<li>Favipiravir</li>
<li>Galidesivir<sup><b>†</b></sup></li>
<li>GS-441524<sup><b>§</b></sup></li>
<li>Remdesivir<sup><b>†</b></sup></li>
<li>MK-608<sup><b>§</b></sup></li>
<li>NITD008<sup><b>§</b></sup></li>
<li>Mericitabine<sup><b>†</b></sup></li>
<li>Merimepodib<sup><b>§</b></sup></li>
<li>Moroxydine</li>
<li>Presatovir<sup><b>†</b></sup></li>
<li><a href="Ribavirin.htm" tppabs="https://ptable.com/wiki/compounds/A/Ribavirin" title="Ribavirin">Ribavirin</a><sup><b>#</b></sup></li>
<li>Taribavirin<sup><b>†</b></sup></li>
<li>Triazavirin</li>
<li>Valopicitabine<sup><b>†</b></sup></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>








<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-04" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Ribavirin&oldid=971093117  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Ribavirin&oldid=971093117'" tppabs="https://en.wikipedia.org/wiki/?title=Ribavirin&oldid=971093117">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>